TENX TENAX THERAPEUTICS INC
FollowCOM NEW (common), issuer CIK 34956
Filings received so far for Q3 2026: 1 13F filer report a position in TENX shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- Dellora Investments LP (group Dellora Investments LP)
2,400,000 shares, 6.4% in a 13G/A as of 2026-10-02,0001943462-26-000008
Accepted , ingested - SPHERA FUNDS MANAGEMENT LTD.(group SPHERA FUNDS MANAGEMENT LTD.)
2,663,296 shares, 7.09% in a 13G/A as of 2026-09-30,0001178913-26-004757
Accepted , ingested
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| GAMMA Investing LLC | 2,591 | $4.9K | <0.01% | new | 13F-HRTimeline |
Events
SPHERA FUNDS MANAGEMENT LTD. and 2 other reporting persons reported 2,663,296 TENX shares, 7.09% of the class, as of 2026-09-30, in a 13G/A filed 2026-10-13. 0001178913-26-004757
Accepted , ingestedDellora Investments LP and 2 other reporting persons reported 2,400,000 TENX shares, 6.4% of the class, as of 2026-10-02, in a 13G/A filed 2026-10-09. 0001943462-26-000008
Accepted , ingested